dopamine agonists

出典: meddic


Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/06/15 02:01:12」(JST)

wiki en

[Wiki en表示]

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.


  • Selective activation of the trace amine-associated receptor 1 decreases cocaine's reinforcing efficacy and prevents cocaine-induced changes in brain reward thresholds.
  • Pei Y1, Mortas P2, Hoener MC2, Canales JJ3.
  • Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2015 Dec 3;63:70-5. doi: 10.1016/j.pnpbp.2015.05.014. Epub 2015 Jun 3.
  • The newly discovered trace amine-associated receptor 1 (TAAR1) has emerged as a promising target for medication development in stimulant addiction due to its ability to regulate dopamine (DA) function and modulate stimulants' effects. Recent findings indicate that TAAR1 activation blocks some of the
  • PMID 26048337
  • Effect of dopamine D4 receptor agonists on sleep architecture in rats.
  • Nakazawa S1, Nakamichi K2, Imai H2, Ichihara J2.
  • Progress in neuro-psychopharmacology & biological psychiatry.Prog Neuropsychopharmacol Biol Psychiatry.2015 Dec 3;63:6-13. doi: 10.1016/j.pnpbp.2015.05.006. Epub 2015 May 16.
  • Dopamine plays a key role in the regulation of sleep-wake states, as revealed by the observation that dopamine-releasing agents such as methylphenidate have wake-promoting effects. However, the precise mechanisms for the wake-promoting effect produced by the enhancement of dopamine transmission are
  • PMID 25985889
  • Synthesis and evaluation in rats of homologous series of [(18)F]-labeled dopamine D 2/3 receptor agonists based on the 2-aminomethylchroman scaffold as potential PET tracers.
  • Shalgunov V1, van Wieringen JP, Janssen HM, Fransen PM, Dierckx RA, Michel MC, Booij J, Elsinga PH.
  • EJNMMI research.EJNMMI Res.2015 Dec;5(1):119. doi: 10.1186/s13550-015-0119-x. Epub 2015 Jul 25.
  • BACKGROUND: Agonist positron emission tomography (PET) tracers for dopamine D2/3 receptors (D2/3Rs) offer greater sensitivity to changes in endogenous dopamine levels than D2/3R antagonist tracers. D2/3R agonist tracers currently available for clinical research are labeled with the short-lived isoto
  • PMID 26205538


  • 先端巨大症の治療戦略
  • 病気について知りたい! 臨床講座(66)パーキンソン病
  • Pharma tribune : なりたい薬剤師になる! 6(6), 23-33, 2014-06
  • NAID 40020138344
  • The effect of dopamine on adult hippocampal neurogenesis
  • Progress in neuro-psychopharmacology & biological psychiatry 50, 116-124, 2014-04-03
  • NAID 120005411146


Dopamine agonist drugs are one of the main ways to treat Parkinson's symptoms. They act like the chemical messenger dopamine to stimulate your nerve cells. ... Parkinson's UK is the operating name of the Parkinson's Disease ...
What are the facts? Dopamine agonists are a different class of drugs than levodopa. While levodopa is converted in the brain into dopamine, dopamine agonists actually mimic the effects of dopamine without having to be converted. ...






dopamine agonistdopaminergic agonistdopaminergic agent, dopaminergic drug, dopamine receptor agonist, dopamine receptor stimulant
[show details]
  • ドパミン作動薬:レボドパ、ブロモクリプチン、インスリン、アルギニン、グルカゴン、プロプラノール(QB.D-254)


  [★] 作動薬

WordNet   license wordnet

「(biochemistry) a drug that can combine with a receptor on a cell to produce a physiological reaction」

WordNet   license wordnet

「a muscle that contracts while another relaxes; "when bending the elbow the biceps are the agonist"」

WordNet   license wordnet

「someone involved in a contest or battle (as in an agon)」


  [★] ドパミン DA

WordNet   license wordnet

「a monoamine neurotransmitter found in the brain and essential for the normal functioning of the central nervous system; as a drug (trade names Dopastat and Intropin) it is used to treat shock and hypotension」
Dopastat, Intropin